First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer.
ACS Pharmacol Transl Sci
; 6(8): 1164-1181, 2023 Aug 11.
Article
in En
| MEDLINE
| ID: mdl-37588763
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Pharmacol Transl Sci
Year:
2023
Type:
Article
Affiliation country:
United States